Industries > Pharma > Artificial Pancreas Device System (APDS) Market Forecast 2020-2030

Artificial Pancreas Device System (APDS) Market Forecast 2020-2030

Artificial Pancreas Device System (APDS) Market Forecast 2020-2030: Forecasts and Analysis by Type (Control-to-Range (CTR) System, Threshold Suspended Device System and Control-to-Target (CTT) System), by Treatment Type (Bi-hormonal, Insulin Only and Hybrid) and Geography with Profiles of Leading Companies

PAGES: 152
PRODUCT CODE: PHA0564
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
SKU: PHA0564 Categories: , Tag:

According to the report published by Visiongain, the Artificial Pancreas Device System (APDS) market is estimated to be valued at USD 187.3 million in 2020 and is expected grow at a CAGR of 20.2% during the forecast period 2020-2030. The artificial pancreas (AP) is an internally carried medical device that mimics the biological pancreas ‘ endocrine role by controlling blood glucose (BGL) levels. It infuses insulin and potentially glucagon to regulate BGL to type 1 diabetic disease in a more streamlined fashion according to an suitable monitoring law. Offering movement, efficiency since using digital communication methods and sophisticated software algorithms it will automatically regulate and control the amount of glucose. In addition to preventing hyperglycemia (increase in glucose concentrations), which in the course of moment contributes to the growth of complications such as: heart, kidney, nose, muscle and foot harm, cardiovascular diseases and Alzheimer’s, while hypoglycemia (fall in glucose concentrations) can be distressing and lead to coma or mortality.
An artificial pancreas, according to the FDA, is a medical device that connects a glucose monitor to an insulin infusion pump where the pump automatically decreases and raises subcutaneous insulin delivery using a command algorithm according to defined subcutaneous glucose concentrations. Because control algorithms can vary significantly, there are a variety of artificial pancreas device systems currently under development. These systems span a wide range of designs from low glucose suspend (LGS) device systems to the more complex bihormonal control-to-target systems.

FDA has described 3 main categories of artificial pancreas device systems:

1. Threshold Suspend Device System With novice suspension cell devices, also known as small glucose suspension devices, insulin delivery is stopped for a fixed moment when 2 concentrations of glucose are below a defined low level of hypoglycemia

2. Control-to-Range System With these technologies, the person establishes his or her own insulin dose within a defined scope, but if glucose concentrations achieve outside that scope (greater or smaller), the artificial pancreas apparatus scheme carries over. Patients using this form of scheme still require blood glucose concentrations to be checked and insulin given as required.

3. Control-to-target scheme The device seeks to keep glucose concentrations close to a goal point, such as 100 mg / dL, with this sort of scheme. Control-to-target devices are automatic and involve no customer involvement except for the ongoing glucose surveillance device calibration. Several apparatus subtypes such as those delivering insulin-only, bi-hormonal devices, and hybrid systems are being created.

During the forecast period, Asia Pacific is anticipated to show the highest development. Due to diet, dna alteration, urbanization and aging, this region has the largest amount of people with diabetes. It is anticipated that increasing diabetes incidences will sustain market growth over the forecast period. Asian nations add more than 60 times to the world’s diabetic population, contributing to the development of the region’s APDS industry, according to an essay released by NCBI. In addition, industry participants are anticipated to increase the industry by extending their facilities across the region. Johnson & Johnson, for example, introduced its Asia Pacific development hub in 2014 to deliver technological progress and improve treatment quality. Such factors are driving the growth of the market.

Growing Prevalence of Diabetes
Diabetes is a chronic disease that is life-threatening without any specific remedy. It is primarily due to the failure of the body to generate or use the hormone insulin efficiently. Diabetes is one of the 21st century’s biggest global health hazards. This disease is experienced by more and more individuals every year, which can lead to life-changing problems. According to the International Diabetes Federation (IDF), there were roughly 46 million individuals with diabetes in North America in 2017, which is anticipated to increase to 62 million in 2045. The rise in the incidence of disease during the forecast period is around 35 percent fold.

Why you should buy Artificial Pancreas Device System (APDS) Market Forecast 2020-2030: Forecasts and Analysis by Type (Control – to – Range (CTR) System, Threshold Suspended Device System, and Control – to – Target (CTT) System), by Treatment Type (Bi-hormonal, Insulin Only, and Hybrid) and Geography, with Profiles of Leading Companies.

What is the future of the Artificial Pancreas Device System (APDS) market?
Visiongain’s comprehensive analysis contains highly quantitative content delivering solid conclusions benefiting your analysis and illustrates new opportunities and potential revenue streams helping you to remain competitive. This definitive report will benefit your decision making and help to direct your future business strategy.

We guarantee in this 171 page report you will receive the following key information

– View Artificial Pancreas Device System (APDS) market forecasts and analysis from 2020-2030 to keep you ahead of your competitors and ensure you exploit key business opportunities
– The report provides detailed sales projections of the market, the competitors, and the commercial drivers and restraints allowing you to more effectively compete in the market. In addition to market forecasts from 2020-2030, our new study shows current market data, original critical analysis, and revealing insight into commercial developments
– Artificial Pancreas Device System (APDS) revenue forecast
– Artificial Pancreas Device System (APDS) connections forecast

– Examine 122 tables, charts, and graphs.
– Let our analysts present you with a thorough assessment of the current and future Artificial Pancreas Device System (APDS) market prospects.
– This analysis will achieve quicker, easier understanding. Also you will gain from our analyst’s industry expertise allowing you to demonstrate your authority on the Artificial Pancreas Device System (APDS) sector

– Discover sales predictions for the key end use submarkets from 2020-2030
– What are the dynamics of the Artificial Pancreas Device System (APDS) industry? Which submarkets will generate the most revenue? Use our forecasts and expert insight to grow your business and give you more industry influence. Find where you can gain and how your organisation can succeed. Avoid falling behind. Stay informed about the potential for each of these Artificial Pancreas Device System (APDS) submarkets with individual forecasts and analysis from 2020-2030.
– Type submarket forecast 2020-2030
– End-Use submarket forecast 2020-2030
– submarket forecast 2020-2030

– Learn about the market prospects for the leading Artificial Pancreas Device System (APDS) market segments 2020-2030
– How will various value chain members perform over the forecast period? Discover where the highest revenue potential lies from 2020-2030, learning about how Artificial Pancreas Device System (APDS) revenue trickles down through the various market segments. These forecasts will also reveal the competitive landscape. You will see what is happening, explaining the challenges, trends, competitors, and market opportunities. Our report reveals forecasts for the 3 leading segmentations as follows.

– Type Revenue Forecast 2020-2030
– CTR (Control to Range) Systems Market Forecast, 2020-2030
– CTT (Control to Target) Systems Market Forecast, 2020-2030
– Other Type Market Forecast, 2020-2030

– End-Use Revenue Forecast 2020-2030
– Hospital Market Forecast, 2020-2030
– Medical Centers Market Forecast, 2020-2030
– Other End-Use Market Forecast, 2020-2030

– Understand the prospects for the 4 regional and the leading 12 national Artificial Pancreas Device System (APDS) markets – where will the highest revenues and opportunities occur?
– Learn about the market potential for Artificial Pancreas Device System (APDS) companies in the developed and developing countries, from 2019 onwards. You will see where and how opportunities exist with revealing individual market forecasts and analysis from 2020-2030 for 12 leading national markets by revenue, as well as segmented regional forecasts

– North America Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– US Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Canada Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Mexico Artificial Pancreas Device System (APDS) revenue forecast 2020-2030

– North America Artificial Pancreas Device System (APDS) by Type revenue forecast 2020-2030
– North America Artificial Pancreas Device System (APDS) by End-Use revenue forecast 2020-2030
– North America Artificial Pancreas Device System (APDS) by revenue forecast 2020-2030
– Asia Pacific Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– China Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Japan Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– India Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Australia Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Rest of Asia Pacific Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Asia Pacific Artificial Pancreas Device System (APDS) by Type revenue forecast 2020-2030
– Asia Pacific Artificial Pancreas Device System (APDS) by End-Use revenue forecast 2020-2030
– Asia Pacific Artificial Pancreas Device System (APDS) by revenue forecast 2020-2030
– European Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Germany Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– UK Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– France Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Italy Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Spain Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Rest of Europe Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– European Artificial Pancreas Device System (APDS) by Type revenue forecast 2020-2030
– European Artificial Pancreas Device System (APDS) by End-Use revenue forecast 2020-2030
– European Artificial Pancreas Device System (APDS) by revenue forecast 2020-2030
– Rest of World Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Rest of World Artificial Pancreas Device System (APDS) by Type revenue forecast 2020-2030
– Rest of World Artificial Pancreas Device System (APDS) by End-Use revenue forecast 2020-2030
– Rest of World Artificial Pancreas Device System (APDS) by revenue forecast 2020-2030

– Explore the factors affecting Artificial Pancreas Device System (APDS) product developers, and everyone within the value chain. Learn about the forces influencing market dynamics.
– Discover what the present and future outlook for business will be. Learn about the following business critical issues
– Research and development (R&D) strategy
– Technological issues and constraints.
– Competition from new product types
– Increasing specialisation by leading players
– Increasing industry consolidation.
– Advances in product quality
– Analysis of barriers to entry

– Identify who the leading companies are in the Artificial Pancreas Device System (APDS) industry
– Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies: See where the expected gains will be. View visiongain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of 10 leading Artificial Pancreas Device System (APDS) companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and future outlook.

Leading Companies in the Global Artificial Pancreas Device System (APDS) Market
Beta Bionics
TypeZero Technologies, LLC
Pancreum, Inc.
Tandem Diabetes Care, Inc.
Johnson & Johnson
Bigfoot Biomedical
Medtronic
DreaMed Diabetes Ltd
Inreda Diabetic BV
Insulet Corporation
Medtrum Technologies Inc.

Discover Information found nowhere else in this independent assessment of the Artificial Pancreas Device System (APDS) market

The Artificial Pancreas Device System (APDS) Market Forecast 2020-2030: Forecasts and Analysis By Type, By End-Use, By and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Artificial Pancreas Device System (APDS) sector analysis. With the independent business intelligence found only in our work, you will discover where the prospects are for profit. In particular, our new research provides you with key strategic advantages: Our informed forecasts, independent and objective analysis, exclusive interviews and revealing company profiles will provide you with that necessary edge, allowing you to gain ground over your competitors.
With this report you are less likely to fall behind in knowledge or miss crucial business opportunities. You will save time and receive recognition for your market insight. See how you this report could benefit and enhance your research, analysis, company presentations and ultimately your individual business decisions and your company’s prospects.

What makes this report unique?
Visiongain’s research methodology involves an exclusive blend of primary and secondary sources providing informed analysis. This methodology allows insight into the key drivers and restraints behind market dynamics and competitive developments. The report therefore presents an ideal balance of qualitative analysis combined with extensive quantitative data including global, submarket and regional markets forecasts from 2020-2030

How the Artificial Pancreas Device System (APDS) Market Forecast 2020-2030: Forecasts and Analysis By Type, By End-Use, By and and Geography, with Profiles of Leading Companies report can benefit you
Visiongain’s report is for anyone requiring analysis of the Artificial Pancreas Device System (APDS) market. You will discover market forecasts, technological trends, predictions and expert opinion providing you with independent analysis derived from our extensive primary and secondary research. Only by purchasing this report will you receive this critical business intelligence revealing where revenue growth is likely and where the lucrative potential market prospects are. Don’t miss this key opportunity to gain a competitive advantage.

Avoid falling behind your competitors, overlooking critical business opportunities or losing industry influence. In our new report you will discover forecasts from 2020-2030 at the global, submarket, and national level. The report also assesses technologies, competitive forces and expected product pipeline developments. Read on to discover the prospects for the Artificial Pancreas Device System (APDS) sector and find out what its future market prospects are.

If you buy our report today your knowledge will stay one step ahead of your competitors. Discover how our report could benefit your research, analyses and strategic decisions, saving you time. To gain an understanding of how to tap into the potential of this market and stay one step ahead of the competition you must order now our report the Artificial Pancreas Device System (APDS) Market Forecast 2020-2030: Forecasts and Analysis By Type, By End-Use, By and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Artificial Pancreas Device System (APDS) sector analysis. Avoid missing out – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

 

Download sample pages

Complete the form below to download your free sample pages for Artificial Pancreas Device System (APDS) Market Forecast 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Artificial Pancreas Device System (APDS) Market Forecast 2020-2030


Latest Pharma news

Visiongain Publishes Pharma Contract Manufacturing Market Report 2020-2030

Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry.

10 August 2020

READ

Visiongain Publishes Biologics Market Report 2020-2030

Biosimilars will be changing the biologics market in the long term. But whether it does it for the better or the worse will depend on how the producers of biologics respond to their market presence.

06 August 2020

READ

Visiongain Publishes Biochips Market Report 2020-2030

Conceptually, it is clear for all stakeholders in the health care segment as well in the biotechnological sector the benefits are evident since it will improve the speed and accuracy of diagnostics or analysis.

05 August 2020

READ

Visiongain Publishes Cell and Gene Supply Chain Services and Solutions Market Report 2020-2030

With the threat of growing number of patients due to the COVID-19 infections, the supply chain trends are looking at a shift with no contact and social distancing policies.

03 August 2020

READ

Categories

Category